The relationship between the responses to prior systemic therapies and the efficacy of subsequent pemetrexed (Pem) therapy in patients (pts) with advanced non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Sun, J. [1 ,2 ]
Oh, D. [1 ,2 ]
Lee, S. [1 ,2 ]
Kim, D. [1 ,2 ]
Im, S. [1 ,2 ]
Kim, T. [1 ,2 ]
Lee, J. [1 ,2 ]
Kim, Y. [1 ,2 ]
Heo, D. S. [1 ,2 ]
Bang, Y. [1 ,2 ]
机构：
[1] Seoul Natl Univ Hosp, Seoul 110744, South Korea
[2] Seoul Natl Univ Hosp, Bundang Hosp, Seoul 110744, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8061
引用
收藏
页数：2
相关论文
共 50 条
  • [41] EFFICACY OF PEMETREXED IN ADVANCED NON-SMALL CELL LUNG CANCER WITH ASYMPTOMATIC BRAIN METASTASES
    Kitai, Hidenori
    Asahina, Hajime
    Takashina, Taichi
    Ikezawa, Yasuyuki
    Sakakibara-Konishi, Jyunn
    Shinagawa, Naofumi
    Oizumi, Satoshi
    Nishimura, Masaharu
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S867 - S867
  • [42] An Overview: Current Systemic Therapies for Advanced Non-Small Cell Lung Cancer
    Ong, Michael
    Vincent, Mark D.
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2011, 7 (05) : 354 - 363
  • [43] Biomarkers and targeted systemic therapies in advanced non-small cell lung cancer
    Kumar, Mukesh
    Ernani, Vinicius
    Owonikoko, Taofeek K.
    MOLECULAR ASPECTS OF MEDICINE, 2015, 45 : 55 - 66
  • [44] Efficacy of individualized chemotherapy (CT) in patients with advanced non-small cell lung cancer (NSCLC)
    Obodnikov, O
    Parshilkov, O
    Orlovskiy, O
    LUNG CANCER, 2005, 49 : S260 - S261
  • [45] Factors predicting the efficacy of gefitinib in patients with advanced non-small cell lung cancer (NSCLC).
    Kishi, K
    Homma, S
    Miyamoto, A
    Sakamoto, S
    Motoi, N
    Yoshimura, K
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 644S - 644S
  • [46] Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC)
    Moya-Horno, Irene
    Viteri, Santiago
    Karachaliou, Niki
    Rosell, Rafael
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10
  • [47] The association between PTEN expression and survival in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with erlotinib
    Hensing, T. A.
    Fidler, M. J.
    Wong, F.
    Polish, A.
    Watkin, W.
    Basu, S.
    Kaiser-Walters, K. A.
    Pool, M.
    Coon, J.
    Bonomi, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [48] A PHASE II TRIAL OF PEMETREXED (P), GEMCITABINE (G), AND BEVACIZUMAB (BV) IN UNTREATED PATIENTS (PTS) WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Wozniak, Antoinette
    Kalemkerian, Gregory
    Gadgeel, Shirish M.
    Ramnath, Nithya
    Schneider, Bryan
    Valdivieso, Manuel
    Smith, Daryn
    Hackstock, Deborah
    Chen, Wei
    Ruckdeschel, John
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1234 - S1235
  • [49] A phase II trial of pemetrexed (P), gemcitabine (G), and bevacizumab (BV) in untreated patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Wozniak, A. J.
    Kalemkerian, G. P.
    Gadgeel, S. M.
    Schneider, B. J.
    Valdivieso, M.
    Venkatramanamoorthy, R.
    Hackstock, D. M.
    Chen, W.
    Heilbrun, L. K.
    Ruckdeschel, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [50] A phase II trial of pemetrexed (P), gemcitabine (G), and bevacizumab (BV) in untreated patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Wozniak, Antoinette J.
    Kalemkerian, Gregory P.
    Gadgeel, Shirish M.
    Schneider, Bryan J.
    Valdivieso, Manuel
    Smith, Daryn
    Hackstock, Deborah M.
    Chen Wei
    Heilbrun, Lance K.
    Ruckdeschel, John D.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S454 - S454
12345